SpringerProtocols: Abstract: Murine Natural Killer Cells and Hybrid Resistance to Hemopoietic Cells In Vivo

Murine Natural Killer Cells and Hybrid Resistance to Hemopoietic Cells In Vivo

By: Jingxuan Liu³, Thaddeus George³, Gene A. Devora³, P. V. Sivakumar³, Colleen Davenport³, Wayne C. Lai³, John Schatzle³, Vinay Kumar³, Michael Bennett³

Abstract

Full Text

Download PDF (119K)

The studies of hybrid resistance (HR) to murine bone marrow cell (BMC) grafts have been helpful in elucidating the biology and genetics of natural killer (NK) cell mediated recognition of incompatible cells (1). The discovery and claim for HR is contrary to the laws of transplantation genetics. Thus rejection of H2^b/d BMC by H2^b/d F1 hybrid mice did not fit with the known codominant inheritance of major histocompatibility complex (MHC) class I and II antigens. The development of the “missing self” hypothesis seems to explain most instances of HR; thus NK cells express a Ly49 family of receptors for “self” class I antigens. The Ly49 molecules and perhaps other receptors on NK cells receive “negative signals” from class I antigens (2). F1 H2^b/d NK cells have two subpopulations of NK cells, those with receptors for H2^d and those with receptors for H2^b. Transplantation of H2^b/b BMC into these H2^b/d hosts results in rejection because the subset of NK cells with receptors for H2^d class I antigens fails to recognize H2^b/b BMC as self. The results of BMC allografts also depend on a donor cell type, called the facilitating cell (FC) (3). FCs were detected when it was observed that BMCs depleted of T cells were hypersusceptible to rejection by irradiated mice; e.g., BMCs from mice with severe combined immunodeficiency (SCID) are strongly rejected (4). Addition of sources of T cells, e.g., thymocytes, can restore the FC and render SCID BMC grafts more like “normal” parental strain BMC grafts. Therefore two donortype cells, stem cells and FCs, are potential targets for rejection by host effector cells. In most instances, the effector cells are NK cells, but sometimes CD8⁺ T cells reject either LNC or BMC allografts (5). We present here our methods for studying murine BMC transplants in mice. Similar studies can also be done with grafts of spleen or lymph node cell (LNC) grafts that undergo graft-vs-host responses (6). Table 1 lists the outcome of BMC grafts in various donor-host combinations, almost always based on H2 type of donor. The NK gene complex on chromosome 6 has one or more genes that confer the relative ability of mice to reject H2 allogeneic or parental-strain BMC grafts (7).

Table 1 Relative Ability of Mice to Reject Allogeneic or Parental-Strain BMC Grafts

BMC
Donor	Host strains
H2 ^a	“good responders”	“poor responders”	H2
b/b	B10.D2, NZB, B10.D2 x DBA/2	BALB/c, DBA/2	d/d
	B10.BR, C57BR, B10.BR x C3H	C3H, CBA	k/k
	B10.A, B10.A x A	A	a/a
	B10 x DBA/2, B10 x B10.D2, 129 x C3H	BALB/cxBALB.B	d/b
d/d	B6, B10, B10 x 129	129, BALB.B,D1.LP	b/b
	B10.BR	C3H, CBA	k/k
	NZB x NZW (H2^d/z)	B6 x DBA/2^b	b/d
		BALB/c x BALB.B	d/b
k/k	NZB	B10.D2, DBA/2, BALB/c	d/d
	None	B10, B6, BALB.B, 129	b/b
	NZB x B6	B6 x DBA/2, B6 x BALB/c	b/d
b/b, D^d	B6, B10	129, BALB.B	b/b
[D8]^c	B10.BR	C3H, CBA	k/k

^aNK subsets that reject H2^b/b BMC include Ly49G2 and Ly49A; those that reject H2^d/d BMC include Ly49C and Ly49I; and both CD8⁺ T cells and NK cells reject H2^k/k BMC.

^bT-cell depleted H2^d/d BMC are rejected (4).

^cD^d is the target antigen of D8 BMC, recognized by host Ly49D receptor lacking immunoreceptor tyrosine-based inhibitory motifs (ITIM) (21).

Affiliation(s): (3) Department of Pathology, University of Texas Southwestern Medical School, Dallas, TX

Book Title: Natural Killer Cell Protocols: Cellular and Molecular Methods

Series: Methods in Molecular Biology | Volume: 121 | Pub. Date: Feb-04-2000 | Page Range: 61-71 | DOI: 10.1385/1-59259-044-6:61

Subject: Immunology

References

Download References

1.	Cudkowicz G. and Bennett M. (1971) Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by F1 hybrid mice. J. Exp. Med. 135, 1513–1528.

2.	Ljunggren H-G. and Kärre K. (1990) In search of the ‘missing self’: MHC molecules and NK recognition. Immunol. Today 11, 237–244.

3.	Kaufman C. L., Colson Y. L., Wren S. M., Watkins S., Simmons R. L., and Ildstat S. L. (1994) Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 84, 2436–2446.

4.	Murphy W. J., Kumar V., Cope J. C., and Bennett M. (1990) An absence of T Cells in murine bone marrow allografts leads to an increased susceptibility to rejection by natural killer cells and T cells. J. Immunol.. 144, 3305–3311.

5.	Davenport C., Kumar V., and Bennett M. (1995) Rapid rejection of H2^k and H2^k/b bone marrow cell grafts by both CD8⁺ T cells and NK cells of irradiated mice. J. Immunol.. 155, 3742–3749.

6.	Bennett M. (1971) Graft-versus-host reactions in mice. I. Kinetic and immunogenetic studies of alloantigen-sensitive units of lymphoid tissue. Transplantation 11, 158–169.

7.	Sentman C. L., Kumar V., Koo G., and Bennett M. (1989) Effector cell expression of NK1. 1, a murine natural killer cell specific molecule, and ability to reject bone marrow allografts. J. Immunol. 142, 1847–1853.

8.	Coligan J. E., Kruisbeek A. M., Margulies D. H., Shevach E. M., and Strober W. (eds.). (1994) Antibody detection and purification in Protocols in Immunology, John Wiley & Sons, Chapter 2.

9.	Donaldson K. L., McShea A., and Wahl A. F. (1997) Separation by counter current elutriation and analysis of T-and B-lymphocytic cell lines in progressive stages of cell division cycle. J. Immunol. Meth. 203, 25–33.

10.	Gao I. K., Noga S. J., Wagner J. E., Cremo C. A., Davis J., and Donnenberg A. D. (1987) Implementation of a semiclosed large scale counterflow centrifugal elutriation system. J. Clin. Apheresis 3, 154–160.

11.	Hengstschlager M., Pusch O., Soucek T., Hengstschlagerrottand E. and Bernaschek G. (1997) Quality control of centrifugal elutriation for studies of cell cycle regulations. BioTechniques 23, 232–237.

12.	Wagner J. E., Donnenberg J. D., Noga S. J., Wiley J. M., Yeager A. M., Vogelsang G. B., Hess A. D., and Santos G. W. (1988) Separation of rat bone marrow cells by counterflow centrifugal elutriation: a model for studying the effects of lymphocyte depletion. Exp. Hematol. 16, 206–212.

13.	Bennett M. Rembecki R. M., Sentman C. L., Murphy W. J., Yu Y. Y. L., Davenport C. and Kumar V. (1993) Bone marrow transplantation and natural killer (NK) cells in mice, in Natural Immunity to Normal Hemopoietic Cells (Rolstad B., ed.), CRC Press, Boca Raton, FL, pp. 33–84.

14.	Bennett M. (1987) Biology and genetics of hybrid resistance. Adv. Immunol. 41, 333–445.

15.	Takei F., Brennan J., and Mager D. L. (1997) The Ly-49 family: genes, proteins and recognitioin of class IMHC. Immunol. Rev. 155, 67–77.

16.	Afifi M. S., Kumar V., and Bennett M. (1985) Stimulation of genetic resistance to marrow grafts by interferon-αβ.J. Immunol. 134, 3739–3745.

17.	Hakim F. T. and Shearer G. M. (1986) Abrogation of hybrid resistance to bone marrow engraftment by graft-vs-host-induced immunosuppression. J. Immunol. 137, 3109–3116.

18.	Cudkowicz G. (1965) Hybrid resistance to parental hematopoietic cell grafts: implications for bone marrow chimeras, in La greffe des Cellules Hématopoïétiques Allogéniques (Mathe G., Amiel J. L., and Schwarzenberg L., eds.), Centre Natl. Rech. Scientif., pp. 207–219.

19.	Kung S. K. P. and Miller R. G. (1997) Mouse natural killer cell subsets defined by their target specificity and their ability to be separately rendered unresponsive in vivo. J. Immunol. 159, 2616–2626.

20.	Murphy W. J., Kumar V., and Bennett M. (1990) Natural killer cells activated by interleukin 2 in vitro can be adoptively transferred and mediate hematopoietic histocompatibility-1 antigen specific bone marrow rejection in vivo. Eur. J. Immunol. 20, 1729–1734.

21.	Sentman C. L., Streilein R., Kumar V., and Bennett M. (1988) Kinetics and location of bone marrow cell (BMC) graft rejection by irradiated mice. Natural Immun. Cell Growth Reg. 7, 95–105.

22.	Raziuddin A., Longo D. L., Mason L., Ortaldo J. R., Bennett M., and Murphy W. J. (1998) Differential effects on the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 NK cell subsets. J. Immunol. 160, 87–94.

Comments (Loading...)

Post comment/View all comments